logo-loader
viewAdial Pharmaceuticals Inc

Adial Pharmaceuticals announces closing of public offering for gross proceeds of $9.2M

The funds will be used for the initial Phase 3 trial of AD04 for the treatment of alcohol use disorder

Illustration of stock
The company closed a public offering of 2,845,000 shares of its common stock and warrants

Adial Pharmaceuticals Inc (NASDAQ:ADIL) announced Tuesday the closing of an underwritten public offering garnering gross proceeds of $9.2 million.

The Charlottesville, Virginia, company said in a statement that the funds will be used for the initial Phase 3 trial of AD04 for the treatment of alcohol use disorder.

Shares of Adial climbed 0.3% to $3.70 in Tuesday’s after-hours trading.

READ: Adial Pharmaceuticals looks to apply its alcohol-use disorder drug to opioid-use disorder

Maxim Group LLC acted as the book-running manager while Joseph Gunnar & Co. acted as a co-manager in connection with the offering.

Adial closed a public offering of 2,845,000 shares of its common stock and warrants to purchase up to 2,133,750 shares of its common stock. That included 370,000 shares of common stock and warrants to purchase up to 277,500 shares of common stock issued upon the partial exercise of the underwriters’ option to buy additional securities to cover overallotments.

Each share of common stock was sold together with a warrant to purchase 0.75 of one share of common stock at a combined price to the public of $3.25.The warrants are immediately exercisable at a price of $4.0625 per share of common stock, subject to adjustment, and will expire five years from the date of issuance

Contact Dennis Fitzgerald at [email protected]

Quick facts: Adial Pharmaceuticals Inc

Price: 2.1 USD

NASDAQ:ADIL
Market: NASDAQ
Market Cap: $21.67 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks slow down but show no signs of giving up last...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, eased 0.9% higher at 125.2 points. Elsewhere, the OTCQX Cannabis index fell 1% to 504.6 points. Buds today are TILT Holdings Inc (CSE:TILT) (OTCMKTS:TLLTF), Aphria Inc (TSE:APHA)...

17 hours, 57 minutes ago

2 min read